Barry Conrad What's your second addition
Dr Flaviano Giorgini, Reader in Neurogenetics of the Universitys Department of Genetics and senior author of the paper, said: We are taking advantage of genetic approaches in simple model organisms in order to better understand Huntingtons disease, with the aim of uncovering novel ways to treat this devastating disorder
Shao W, Chen R, Lin G, Ran K, Zhang Y, Yang J
Setting honest expectations is important with any IV drip treatment
[6] Triggers [edit] Carriers of the underlying mutation do not show any symptoms unless their red blood cells are exposed to certain triggers, which can be of four main types: Foods (fava beans is the hallmark trigger for G6PD mutation carriers) Certain medicines including rasburicase, primaquine and other antimalarials[PMID 36049896] Moth balls (naphthalene) [9] Stress from a bacterial or viral infection [10] Drugs [edit] Many substances are potentially harmful to people with G6PD deficiency
Update of a Phase I study of sorafenib in patients with refractory/relapsed acute myeloid leukemia or high-risk myelodysplastic syndrome